PDLIM7 and extranodal nasal NK/T cell lymphoma: In a study of 10 NKTCL patients (8 with localized disease and 2 with advanced disease) who received autologous LMP-specific CTLs after achieving CR with induction therapy, the 4-year OS and PFS rate were 100% and 90%, respectively [72].